EP3612537

Pýrrólóbensódíasepín samtengingar

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    18.4.2018
  • EP published:
    13.7.2022
  • EP application number:
    18718452.8
  • Max expiry date:
    17.4.2038
  • Expiry date:
    17.4.2026
  • Next due date:
    30.4.2026
  • Title in English:
    PYRROLOBENZODIAZEPINE CONJUGATES
  • Language of the patent:
    English

Timeline

Today
18.4.2018EP application
13.7.2022EP Publication
22.8.2022Translation submitted
15.9.2022Registration published
17.4.2026Expires

Owner

  • Name:
    Medimmune Limited
  • Address:
    Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB

Inventor

  • Name:
    HOWARD, Philip Wilson
  • Address:
    Cambridge Cambridgeshire CB21 6GH, GB
  • Name:
    GREGSON, Stephen John
  • Address:
    Cambridge Cambridgeshire CB21 6GH, GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201706133
  • Date:
    18.4.2017
  • Country:
    GB
  • Number:
    201721337
  • Date:
    19.12.2017
  • Country:
    GB

Classification

  • Categories:
    C07D 519/00, A61P 35/00, A61K 47/68, C07K 5/062

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 11.4.2023

Expires: 17.4.2024

Payer: Árnason Faktor ehf.

Number: 7

Paid: 20.3.2024

Expires: 17.4.2025

Payer: Árnason Faktor ehf.

Number: 8

Paid: 8.4.2025

Expires: 17.4.2026

Payer: Árnason Faktor ehf.

Upload documents